Verenium +57% premarket after BASF buyout offer

|About: Verenium Corporation (VRNM)|By:, SA News Editor

Industrial biotech company Verenium (VRNM) +57.7% premarket after agreeing to be acquired by BASF (BASFY.PK) for ~$51.2M, or $4/share, a 59% premium to Thursday's closing price.

VRNM focuses on developing and selling high-performance enzymes used in food and fuel markets.